FinnCap reissued their corporate rating on shares of OptiBiotix Health PLC (LON:OPTI) in a research note published on Wednesday morning.

OptiBiotix Health PLC (LON:OPTI) opened at 68.00 on Wednesday. The firm’s market cap is GBX 53.41 million. OptiBiotix Health PLC has a 52-week low of GBX 59.00 and a 52-week high of GBX 90.00. The company’s 50-day moving average price is GBX 67.25 and its 200-day moving average price is GBX 70.65.

COPYRIGHT VIOLATION NOTICE: This story was originally published by Daily Political and is owned by of Daily Political. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at

OptiBiotix Health PLC Company Profile

Optibiotix Health Plc is a life sciences company developing a range of products to modify the human microbiome. The Company’s principal activity is research and development into microbiome modulators. It operates in UK segment. The Company has a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest and appetite suppression.

Receive News & Ratings for OptiBiotix Health PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptiBiotix Health PLC and related companies with's FREE daily email newsletter.